Clinical predictors of Pneumocystis carinii pneumonia bacterial pneumonia and tuberculosis in HIV-infected patients

AIDS

Volumn 12, Issue 8, 1998, Pages 885-893

  Selwyn, Peter A ^a   Pumerantz, Andrew S ^a   Durante, Amanda ^a   Alcabes, Phillip G ^a   Gourevitch, Marc N ^b   Boiselle, Phillip M ^a   Elmore, Joann G ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Bacterial pneumonia; Pneumocystis carinii pneumonia; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL PNEUMONIA; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THRUSH; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOSPITALS, TEACHING; HOSPITALS, URBAN; HUMANS; MALE; ODDS RATIO; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCYSTIS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 0032574898     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00011     Document Type: Article

References (33)

1. Murray JF, Felton CP, Garay JM, et al.: Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung and Blood Institute workshop. N Engl J Med 1984, 312:1682-1688.
2. Greenberg AE, Thomas PA, Landesman SH, et al.: The spectrum of HIV-1-related disease among outpatients in New York City. AIDS 1992, 6:849-859.
3. Farizo KM, Buehler JW, Chamberland ME, et al.: Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992, 267:1798-1805.
4. Hirschtick RE, Glassroth J, Jordan MC, et al.: Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995, 333:845-851.
5. Glatt AE, Chirgwin K: Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med 1990, 150:271-279.
6. Hopewell PC: Impact of human immunodeficiency virus infection on the epidemiology clinical features, management, and control of tuberculosis. Clin Infect Dis 1992, 15:540-547.
7. Selwyn PA, Alcabes P, Hartel D, et al.: Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992, 327:1697-1703.
8. Caiaffa WT, Graham NM, Vlahov D: Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993, 138:909-922.
9. Chaisson RE: Bacterial pneumonia in patients with human immunodeficiency virus infection. Semin Respir Infect 1989, 4:133-138.
10. Wallace JM, Hansen NI, Lavange L, et al.: Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997, 115:72-80.
11. Wallace JM, Rao AV, Glassroth J, et al.: Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1523-1529.
12. Centers for Disease Control and Prevention: AIDS associated with injecting-drug use: United States, 1995. MMWR 1996, 45:392-398.
13. Lin-Greenberg A, Anez T: Delay in respiratory isolation of patients with pulmonary tuberculosis and human immunodeficiency virus infection. Am J Infect Control 1992, 20:16-18.
14. Chave JP, Bille J, Glauser MP, Francioli P: Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virus, Eur J Clin Microbiol Infect Dis 1989, 8:123-126.
15. Katz MH, Baron RB, Grady D: Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia. Arch Intern Med 1991, 151:105-110.
16. Magnenat JL, Nicod LP, Auckenthaler R, Junod AF: Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis 1991, 144:917-922.
17. Amorosa JK, Nahass RG, Nosher JL, Gocke DJ: Radiologic distinction of pyogenic pulmonary infection from Pneumocystis carinii pneumonia in AIDS patients. Radiology 1990, 175:721-724.
18. Barnes PF, Steele MA, Young SM, Vachon LA: Tuberculosis in patients with human immunodeficiency virus infection. How often does it mimic Pneumocystis carinii pneumonia? Chest 1992, 102:428-432.
19. Opravil M, Marincek B, Fuchs WA, et al.: Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1994, 7:39-45.
20. Friedland CH, Saltzman B, Vileno J, Freeman K, Schrager LK, Klein RS: Survival differences in patients with AIDS. J Acquir Immune Defic Syndr 1991, 4:144-153.
21. Schrager L, Friedland G, Feiner C, Kahl P: Demographic characteristics, drug use, and sexual behaviors of intravenous drug users with AIDS in Bronx, NY. Public Health Rep 1991, 106:78-84.
22. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1S):1S-15S.
23. Boiselle PM, Tocino I, Hooley RJ, et al.: Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thorac Imaging 1997, 12:47-53.
24. Laing R, Brettle R, Leen C, Hulks G: Features and outcome of Pneumocystis carinii pneumonia according to risk category for HIV infection. Scand J Infect Dis 1997, 29:57-61.
25. Caiaffa WT, Vlahov D, Graham NM, et al.: Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med 1994, 150:1493-1498.
26. Kagawa FT, Kirsch CM, Yenokida CC, Levine ML: Serum lactate dehydrogenase activity in patients with AIDS and Pneumocystis carinii pneumonia: an adjunct to diagnosis. Chest 1988, 94:1031-1033.
27. Boudes P, Furhman C, Verra F, Sobel A: Value of the LDH level in Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Ann Intern Med 1990, 141:175-178.
28. Chouaid C, Maillard D, Housset B, Febvre M, Zaoui D, Lebeau B: Cost effectiveness of noninvasive oxygen saturation measurement during exercise for the diagnosis of Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993, 147:1360-1363.
29. Boldt MJ, Bai TR: Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest 1997, 111:1187-1192.
30. Quist J, Hill AR: Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest 1995, 108:415-418.
31. Barnes PF, Bloch AB, Davidson PT, Snider Jr DE: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991, 324:1644-1650.
32. Huang L, Hecht FM, Gruden JF, et al.: Predicting Pneumocystis carinii pneumonia: results of a multivariate analysis. IX International Conference on AIDS. Vancouver, July 1996 [abstract TuB110].
33. Frieden TR, Sherman LF, May KL, et al.: A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996, 276:1229-1235.